Core Viewpoint - Madison Square Garden Entertainment Corp. (MSGE) is a significant entity in the entertainment sector, recognized for its renowned venues and live events, competing with other major players in a dynamic market [1] Group 1: Stock Performance and Ratings - On December 16, 2025, Seaport Global upgraded MSGE to a "Buy" rating, increasing the price target from $51 to $62, indicating optimism about the company's future performance [2][6] - Currently, MSGE is priced at $52.07, showing a slight decrease of approximately 1.20%, with a trading range today between $51.97 and $53.22 [5] Group 2: Institutional Investor Activity - AWH Capital L.P. increased its stake in MSGE by 15.8%, now holding 110,000 shares valued at approximately $4.4 million, reflecting confidence in MSGE's growth potential [3][6] - Other institutional investors have also shown interest, with BI Asset Management initiating a new position valued at around $40,000, and CWM LLC significantly increasing its stake by 623.8% [4][6]

SAN FRANCISCO--(BUSINESS WIRE)--Levi Strauss & Co. (LS&Co.) (NYSE: LEVI) announced today that its board of directors has appointed Jeffrey J. Jones II to serve as a member of the board, effective January 21, 2026, at which time he'll serve as a member of the board's Nominating, Governance and Corporate Citizenship Committee as well as the Compensation and Human Capital Committee. Mr. Jones has served as President and CEO and Director of H&R Block, Inc. (NYSE: HRB) since 2017 and bri. ...

MISSISSAUGA, Ontario, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Bird Construction Inc. (TSX: BDT) is pleased to announce the award of multiple projects and agreements totaling approximately $1.2 billion, spanning major industrial capital investment projects and a series of significant new and renewed multi-year master service agreements (MSA) with both new and existing clients. Bird’s Industrial Maintenance team, through its existing Indigenous Limited Partnership between Stuart Olson and Infinity Métis Corporation ...

RIDGELAND, Miss., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based prepared food industry, today announced it will report results for its fiscal 2026 second quarter at approximately 6:00 a.m. ET on Wednesday, January 7, 2026. The earnings release will be available on the Cal-Maine Foods website at https://www.calmainefoods.com/press-releases. Management will review the results during a conference call a ...

Montreal, Quebec--(Newsfile Corp. - December 16, 2025) - Amex Exploration Inc. (TSXV: AMX) (FSE: MX0) (OTCQX: AMXEF) ("Amex" or "the Company") is pleased to announce the closing of its acquisition (the "Transaction") of a 100% undivided interest in the 324 non-contiguous mining claims comprising 8,392.92 hectares in the Abbotsford and Hepburn Townships in the province of Ontario. The Transaction was completed pursuant to the terms and conditions of the definitive asset purchase agreement entered into betwe ...

  NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.Langley, British Columbia – December 16, 2025 – TheNewswire - Viva Gold Corp. (“Viva Gold” or the “Company”) (TSXV: VAU, OTCQB: VAUCF) is pleased to announce that, due to strong investor demand, it has increased the size of its previously announced non-brokered private placement financing (the “Offering”), originally announced on December 11, 2025.The Company has upsized the Offering from up to 18,750,000 u ...

® SAN DIEGO, Dec. 16, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology today announced an update on the INBRX-106 Phase 2/3 clinical trial in combination with Keytruda (pembrolizumab) as a first-line treatment for patients with locally advanced unresectable or metastatic head and neck squamous cell carcinoma (HNSCC) and the Phase 1/2 trial evaluating patients with checkpoint ...

Tilray’s jump in a broad cannabis rally shows how shifting U.S. policy signals are jolting traders, today, Dec. 16, 2025.NASDAQ : TLRYTilray BrandsToday's Change( 27.54 %) $ 3.01Current Price$ 13.94Key Data PointsMarket Cap$1.3BDay's Range$ 10.50 - $ 14.5552wk Range$ 3.51 - $ 23.20Volume47MAvg Vol9MGross Margin20.17 %Tilray Brands (TLRY +27.54%), global medical cannabis producer, closed Tuesday’s session at $13.94, up 27.54%. Trading volume reached 46.8 million shares, about 525% above its three-month avera ...

BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (the “Company” or “Galecto”) (Nasdaq: GLTO) today announced that the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 312,535 shares of the Company’s common stock to one new employee (the “Inducement Grant”) on December 15, 2025 (the “Grant Date”). The Inducement Grant has been granted pursuant to the Company’s 2022 Inducement Plan, as amended from time to time. The Inducement Grant was granted as an inducement ...

Group 1 - The discussion focuses on the growth of volume in the Buy Now, Pay Later (BNPL) sector, highlighting its increasing popularity among consumers in the U.S. [1] - Affirm, as a key player in the BNPL market, is noted for its ability to engage with retail investors and address their inquiries, indicating a strong interest in the company's performance and strategies [1] - The success of BNPL is attributed to the variety of payment methods available to consumers, suggesting that the flexibility and convenience offered by BNPL solutions resonate well with consumer preferences [1]